| Michael W Ritter, MD | |
|
7610 Sawmill Rd, Madison, WI 53717-2207 | |
| (608) 831-1528 | |
| Not Available |
| Full Name | Michael W Ritter |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Allergy/immunology |
| Location | 7610 Sawmill Rd, Madison, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003885351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0201X | Pediatrics - Pediatric Allergy/immunology | 28907 (Wisconsin) | Primary |
| 207RA0201X | Internal Medicine - Allergy & Immunology | 28907 (Wisconsin) | Secondary |
| Entity Name | University Of Wisconsin Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
Ordinary face masks and hand hygiene can effectively reduce the transmission of influenza-like illness during flu season. The finding comes from a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650396), published in the Feb. 15 issue of the Journal of Infectious Diseases.
Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.
Autoimmune diseases like Crohn's Disease and multiple sclerosis, in which the immune system attacks its own body rather than predatory invaders, affect 5-20% of the global community. A study published recently in Autoimmunity Reviews by Prof. Yehuda Shoenfeld, the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at Tel Aviv University's Sackler Faculty of Medicine and Head of Zabludowicz Center for Autoimmune Diseases at Chaim Sheba Medical Center, Tel Hashomer, points to the major role obesity plays in triggering and prolonging these autoimmune diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael W Ritter, MD 7610 Sawmill Rd, Madison, WI 53717-2207 Ph: () - | Michael W Ritter, MD 7610 Sawmill Rd, Madison, WI 53717-2207 Ph: (608) 831-1528 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
Ordinary face masks and hand hygiene can effectively reduce the transmission of influenza-like illness during flu season. The finding comes from a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650396), published in the Feb. 15 issue of the Journal of Infectious Diseases.
Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.
Autoimmune diseases like Crohn's Disease and multiple sclerosis, in which the immune system attacks its own body rather than predatory invaders, affect 5-20% of the global community. A study published recently in Autoimmunity Reviews by Prof. Yehuda Shoenfeld, the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at Tel Aviv University's Sackler Faculty of Medicine and Head of Zabludowicz Center for Autoimmune Diseases at Chaim Sheba Medical Center, Tel Hashomer, points to the major role obesity plays in triggering and prolonging these autoimmune diseases.
› Verified 9 days ago
Dr. Emily Ann Forster, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Daniel J Jackson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Csc Box 9988, Madison, WI 53792 Phone: 608-239-3515 | |
Dr. Elma O Sia, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4410 Regent St, Madison, WI 53705 Phone: 608-233-9746 | |
Patricia V Staats, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1217 Gilbert Rd, Madison, WI 53711 Phone: 608-274-3636 | |
Dr. Jesse Roach, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6420 | |
Norris Glick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 317 Knutson Drive, Madison, WI 53704 Phone: 608-301-1791 |